SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, driven by stronger demand for Amtagvi, is the main catalyst behind the sharp rally, with analyst upgrades adding to bullish sentiment. Traders are also citing possible short covering and prospective lung-cancer data, while some warn about profit-taking and dilution risk.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is under pressure as traders debate whether Kalshi and Polymarket are taking wagering share and forcing higher spending that could weigh on margins. Bears see a growing competitive threat, while bulls point to rising DKeX activity and sportsbook handle as signs the company can compete.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after the FHFA moved to put VantageScore alongside FICO in a unified mortgage-pricing framework, raising concerns that FICOs longstanding advantage in mortgage credit scoring could erode. Traders are divided between viewing the move as a serious threat to its pricing power and an overreaction, arguing FICO remains deeply embedded in lending.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and lifted its full-year outlook, with record customer deposits and strong 2027 bookings pointing to resilient cruise demand; the news drove a sharp rally and lifted other cruise stocks. Bulls welcomed the results and stronger booking outlook, while bears pointed to fuel costs, margin pressure and weaker near-term guidance as risks.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention for sharp volatility, with traders focused on upcoming insider share unlocks as a potential source of selling pressure. The debate pits that supply overhang and broader AI-stock weakness against optimism about Cerebras inference business and customer partnerships.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is drawing attention after a Bank of America upgrade tied to the potential for Google ad-tech remedies to improve independent exchanges access to advertising spend. Traders welcomed the upgrade and sharp rally, though some questioned whether the move can hold after similar rallies faded.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures four-year AMT-130 Huntingtons disease update showed less slowing of progression on the cUHDRS measure than the three-year results, and the four-year result was not statistically significant, driving a sharp selloff. Traders are split between viewing the update as a durability concern and calling the drop an overreaction because the BLA is based on the FDA-accepted three-year data; some also question the external-control analysis.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

CEO C.J. Desais abrupt departure for Meta ahead of MongoDBs Investor Day is driving attention, with former CEO Dev Ittycheria returning as interim chief. Traders are split between concern about leadership uncertainty and viewing the selloff as an overreaction, pointing to reaffirmed guidance and AI-related product announcements as reasons for optimism.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635s positive Phase 2 results for menopausal hot flashes and anticipation of a fuller data presentation at the IMS World Congress; traders are also discussing the drugs potential path to Phase 3 and AbCelleras ability to turn its antibody platform into clinical assets. Bulls see the data and presentation as support for further gains, while some claims that specific 12-week results or a partnership are imminent remain speculation.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation high-voltage silicon-carbide semiconductors is driving attention, with traders viewing the award as technology validation and a possible step toward defense and AI-infrastructure opportunities. The community is split between bullish takes on the strategic value and concerns that it is a prototype award with no disclosed financial terms or clear near-term revenue, especially after the initial pop faded.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RYTHM Swings to Earnings in Q2 on THC Beverage Growth

RYM swings to a second-quarter earnings per share as revenues surge, supported by THC beverage momentum and the amended Green Thumb Industries licensing agreement.


RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits

RYTHM swings to earnings in the first quarter as revenues surge, margins improve and THC beverage demand remains strong, while management projects robust sequential sales growth.


RYTHM (NASDAQ:RYM) Issues Earnings Results

RYTHM (NASDAQ:RYM - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $1.33 earnings per share for the quarter. RYTHM had a negative return on equity of 191.60% and a negative net margin of 192.43...

RYTHM (NASDAQ:RYM) Shares Up 7.8% - What's Next?

RYTHM (NASDAQ:RYM) Trading Up 7.8% - Still a Buy...

Top Cannabis Stocks To Watch Now - April 4th

Tilray Brands, Canopy Growth, Aurora Cannabis, Quantum Biopharma, Cronos Group, SNDL, and RYTHM are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis...

RYM Stock Surges 45%, Breaches 100-DMA For First Time In Over Three Months – What Triggered This Rally?

Equity

Rythm announced amendments to its licensing agreements with Green Thumb, under which it would be paid a fixed annual cash fee of $70 million.

Promising Cannabis Stocks To Follow Today - April 1st

Tilray Brands, Quantum Biopharma, RYTHM, Canopy Growth, and Aurora Cannabis are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are publicly...

RYTHM's Q4 Loss Narrows Y/Y on Licensing Revenue Growth

RYM's Q4 net loss per share narrows year over year as revenue surged, driven by strong licensing income and expanding distribution of its hemp-derived THC beverages.

RYTHM (NASDAQ:RYM) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered RYTHM from a "hold" rating to a "sell" rating in a research report on Saturday...

Best Agriculture Stocks Worth Watching - December 14th

Deere & Company, Corteva, Bunge Global, RYTHM, and Cal-Maine Foods are the five Agriculture stocks to watch today, according to MarketBeat's stock screener tool. Agriculture stocks are shares of...

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

Bearish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Current Price	$21.23
Prev Close	$21.44
Open	$21.27
Dividend Yield	0.00%
50-Day Moving Average	$21.92
Beta	1.05
Avg. Volume	11,163.11
PE Ratio	-1.91

52-Week High	$53.65
52-Week Low	$14.00
Market Capitalization	$46.72M
EPS (Annual)	-$18.45
Price to Book	1.18
Revenue Per Employee	$338,882.35

Feed

News

Sentiment

Fundamentals

Info

RYM Fundamentals